47 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Article Searches
HealthEquity, Inc. (HQY) Q4 2024 Earnings Call Transcript https://seekingalpha.com/article/4679248-healthequity-inc-hqy-q4-2024-earnings-call-transcript?source=feed_sector_transcripts Mar 19, 2024 - HealthEquity, Inc. (NASDAQ:NASDAQ:HQY) Q4 2024 Results Conference Call March 19, 2024 4:30 PM ETCompany ParticipantsRichard Putnam - Investor RelationsJon...
Compared to Estimates, HealthEquity (HQY) Q4 Earnings: A Look at Key Metrics https://www.zacks.com/stock/news/2243114/compared-to-estimates-healthequity-hqy-q4-earnings-a-look-at-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm-2243114 Mar 19, 2024 - The headline numbers for HealthEquity (HQY) give insight into how the company performed in the quarter ended January 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Here's Why You Should Retain HealthEquity (HQY) Stock Now https://www.zacks.com/stock/news/2242869/here-s-why-you-should-retain-healthequity-hqy-stock-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2242869 Mar 19, 2024 - HealthEquity's (HQY) strength in HSAs raises optimism about the stock.
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick https://www.zacks.com/stock/news/2241382/are-you-a-growth-investor-this-1-stock-could-be-the-perfect-pick?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_growth_score-2241382 Mar 15, 2024 - Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
HealthEquity (HQY) Reports Next Week: Wall Street Expects Earnings Growth https://www.zacks.com/stock/news/2239310/healthequity-hqy-reports-next-week-wall-street-expects-earnings-growth?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_9-2239310 Mar 12, 2024 - HealthEquity (HQY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why HealthEquity (HQY) is a Top Momentum Stock for the Long-Term https://www.zacks.com/stock/news/2234658/why-healthequity-hqy-is-a-top-momentum-stock-for-the-long-term?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_momentum_score-2234658 Mar 01, 2024 - Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why HealthEquity (HQY) is Poised to Beat Earnings Estimates Again https://www.zacks.com/stock/news/2232650/why-healthequity-hqy-is-poised-to-beat-earnings-estimates-again?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_7-2232650 Feb 27, 2024 - HealthEquity (HQY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
3 Medical Services Stocks to Buy Amid Industry Headwinds https://www.zacks.com/commentary/2224052/3-medical-services-stocks-to-buy-amid-industry-headwinds?cid=CS-ZC-FT-industry_outlook-2224052 Feb 09, 2024 - The Zacks Medical - Services industry is growing on digital healthcare adoption. ELV, COR and HQY are set to gain the most. However, staffing shortages continue to disrupt the growth trend.
HealthEquity, Inc. (HQY) Hit a 52 Week High, Can the Run Continue? https://www.zacks.com/stock/news/2216440/healthequity-inc-hqy-hit-a-52-week-high-can-the-run-continue?cid=CS-ZC-FT-52_week_high-2216440 Jan 26, 2024 - HealthEquity (HQY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Penumbra (PEN) Rides on Vascular Arm Strength Amid FX Woes https://www.zacks.com/stock/news/2212281/penumbra-pen-rides-on-vascular-arm-strength-amid-fx-woes?cid=CS-ZC-FT-analyst_blog|zer_report_update-2212281 Jan 18, 2024 - Penumbra's (PEN) Vascular business is demonstrating strong growth, banking on a rapid increase in sales of vascular thrombectomy products in the United States.

Pages: 12345

Page 1>